トップページ > グループ紹介 > 粒子線医学開発分野（柏） > 業績

業績

2021年度

  1. Matsuda Y, Yamaguchi T, Matsumoto Y, Ishiki H, Usui Y, Kako J, Suzuki K, Matsunuma R, Mori M, Watanabe H, Zenda S. Research policy in supportive care and palliative care for cancer dyspnea. Jpn J Clin Oncol. 2022 Mar 3;52(3):260-265. doi: 10.1093/jjco/hyab193.
  2. Du J, Kageyama SI, Yamashita R, Hirata H, Hakozaki Y, Okumura M, Motegi A, Hojo H, Nakamura M, Hirano Y, Sunakawa H, Minamide T, Kotani D, Tanaka K, Yano T, Kojima T, Ohashi A, Tsuchihara K, Akimoto T. Impacts of the STING-IFNAR1-STAT1-IRF1 pathway on the cellular immune reaction induced by fractionated irradiation. Cancer Sci. 2022 Feb 8. doi: 10.1111/cas.15297. Online ahead of print.
  3. Fukushima T, Tsuji T, Watanabe N, Sakurai T, St AM, St KK, Yahiro S, Oki M, Okita Y, Yokota S, Nakano J, Sugihara S, Sato H, Kawakami J, Kagaya H, Tanuma A, Sekine R, Mori K, Zenda S, Kawai A. Cancer Rehabilitation Provided by Designated Cancer Hospitals in Japan: The Current State of Outpatient Setting and Coordination after Discharge. Prog Rehabil Med. 2022 Feb 10;7:20220006. doi: 10.2490/prm.20220006.
  4. Okumura M, Du J, Kageyama SI, Yamashita R, Hakozaki Y, Motegi A, Hojo H, Nakamura M, Hirano Y, Okuma Y, Okuma HS, Tsuchihara K, Akimoto T. Comprehensive screening for drugs that modify radiation-induced immune responses. Br J Cancer. 2022 Feb 19. doi: 10.1038/s41416-021-01688-0. Online ahead of print.
  5. Akiyama N, Okamura T, Yoshida M, Kimura SI, Yano S, Yoshida I, Kusaba H, Takahashi K, Fujita H, Fukushima K, Iwasaki H, Tamura K, Saeki T, Takamatsu Y, Zenda S. Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons. Support Care Cancer. 2022 May;30(5):4327-4336. doi: 10.1007/s00520-022-06834-9.
  6. Du J, Kageyama SI, Hirata H, Motegi A, Nakamura M, Hirano Y, Okumura M, Yamashita R, Tsuchihara K, Hojo H, Hirayama R, Akimoto T. Comparative analysis of the immune responses in cancer cells irradiated with X-ray, proton and carbon-ion beams. Biochem Biophys Res Commun. 2021 Dec 31;585:55-60. doi: 10.1016/j.bbrc.2021.11.004.
  7. Akiyama N, Okamura T, Yoshida M, Kimura SI, Yano S, Yoshida I, Kusaba H, Takahashi K, Fujita H, Fukushima K, Iwasaki H, Tamura K, Saeki T, Takamatsu Y, Zenda S. A questionnaire survey on evaluation for penetration and compliance of the Japanese Guideline on Febrile Neutropenia among hematology-oncology physicians and surgeons. Support Care Cancer. 2021 Nov;29(11):6831-6839. doi: 10.1007/s00520-021-06277-8.
  8. Yokota T, Zenda S, Ota I, Yamazaki T, Yamaguchi T, Ogawa T, Tachibana H, Toshiyasu T, Homma A, Miyaji T, Mashiko T, Hamauchi S, Tominaga K, Ishii S, Otani Y, Orito N, Uchitomi Y. Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation. Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):794-803. doi: 10.1016/j.ijrobp.2021.05.133.
  9. Hirata H, Niida A, Kakiuchi N, Uchi R, Sugimachi K, Masuda T, Saito T, Kageyama SI, Motomura Y, Ito S, Yoshitake T, Tsurumaru D, Nishimuta Y, Yokoyama A, Hasegawa T, Chiba K, Shiraishi Y, Du J, Miura F, Morita M, Toh Y, Hirakawa M, Shioyama Y, Ito T, Akimoto T, Miyano S, Shibata T, Mori M, Suzuki Y, Ogawa S, Ishigami K, Mimori K. The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy. Cancer Res. 2021 Oct 1;81(19):4926-4938. doi: 10.1158/0008-5472.CAN-21-0653.
  10. Okumura M, Hojo H, Nakamura M, Hiyama T, Nakamura N, Zenda S, Motegi A, Hirano Y, Kageyama SI, Parshuram RV, Fujisawa T, Kuno H, Akimoto T. Radiation pneumonitis after palliative radiotherapy in cancer patients with interstitial lung disease. Radiother Oncol. 2021 Aug; 161:47-54. doi: 10.1016/j.radonc.2021.05.026.
  11. Mizumoto M, Fuji H, Miyachi M, Soejima T, Yamamoto T, Aibe N, Demizu Y, Iwata H, Hashimoto T, Motegi A, Kawamura A, Terashima K, Fukushima T, Nakao T, Takada A, Sumi M, Oshima J, Moriwaki K, Nozaki M, Ishida Y, Kosaka Y, Ae K, Hosono A, Harada H, Ogo E, Akimoto T, Saito T, Fukushima H, Suzuki R, Takahashi M, Matsuo T, Matsumura A, Masaki H, Hosoi H, Shigematsu N, Sakurai H. Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines. Cancer Treat Rev. 2021 Jul; 98:102209. doi: 10.1016/j.ctrv.2021.102209.
  12. Komine R, Kojima M, Ishi G, Kudo M, Sugimoto M, Kobayashi S, Takahashi S, Konishi M, Kobayashi T, Akimoto T, Murakami A, Sasaki M, Tanaka M, Matsuzaki A, Ohike N, Uchida K, Sugiyama T, Hirabayashi K, Tajiri T, Ishida K, Kai K, Omori Y, Notohara K, Yamaguchi H, Matsuda Y, Naito Y, Fukumura Y, Hamada Y, Mihara Y, Masugi Y, Gotohda N, Harada K, Fukushima N, Furukawa T. Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin. Cancer Med. 2021 Jun;10(11):3499-3510. doi:10.1002/cam4.3809.
  13. Nakajo K, Yoda Y, Kadota T, Murano T, Shinmura K, Ikematsu H, AkimotoT, Yano T. Radial incision and cutting for dilation before endoscopic submucosal dissection in patients with esophageal cancer on the distal side of severe benign esophageal strictures. Dis Esophagus. 2021 Jun 14;34(6):doaa092. doi:10.1093/dote/doaa092.
  14. Nozaki M, Kagami Y, Machida R, Nakamura K, Ito Y, Nishimura Y, Teshima T, Saito Y, Nagata Y, Matsumoto Y, Akimoto T, Hiraoka M; Japan Clinical Oncology Group, Radiation Therapy Study Group. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Jpn J Clin Oncol. 2021 May 28;51(6):865-872. doi: 10.1093/jjco/hyab024.
  15. Raturi VP, Motegi A, Zenda S, Nakamura N, Hojo H, Kageyama SI, Okumura M, Rachi T, Ohyoshi H, Tachibana H, Motegi K, Ariji T, Nakamura M, Hirano Y, Hirata H, Akimoto T. Comparison of a Hybrid IMRT/VMAT technique with non-coplanar VMAT and non-coplanar IMRT for unresectable olfactory neuroblastoma using the RayStation treatment planning system-EUD, NTCP and planning study. J Radiat Res. 2021 May 12;62(3):540-548. doi: 10.1093/jrr/rrab010.
  16. Sunakawa H, Yoda Y, Takeshita N, Hasegawa H, Takashima K, Kadota T, Fujita T, Akimoto T, Fujii S, Yano T. Endoscopic resection combined with the Cryoballoon focal ablation system in the porcine normal esophagus: a preclinical study. BMC Gastroenterol. 2021 May 22;21(1):234. doi: 10.1186/s12876-021-01819-0.
  17. Iwai K, Nambu T, Kashima Y, Yu J, Eng K, Miyamoto K, Kakoi K, Gotou M, Takeuchi T, Kogame A, Sappal J, Murai S, Haeno H, Kageyama SI, Kurasawa O, Niu H, Kannan K, Ohashi A. A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery. Sci Adv. 2021 May 21;7(21):eabf0197. doi: 10.1126/sciadv.abf0197.
  18. Aibe N, Ogino H, Teramukai S, Yamazaki H, Iwata H, Matsuo Y, Okimoto T, Murakami M, Suzuki M, Arimura T, Ogino T, Murayama S, Harada H, Nakamura M, Akimoto T, Sakurai H. Multi-Institutional Retrospective Analysis of the Outcomes of Proton Beam Therapy for Patients With 1 to 3 Pulmonary Oligometastases From Various Primary Cancers. Adv Radiat Oncol. 2021 Jul-Aug; 6(4):100690. doi: 10.1016/j.adro.2021.100690.
  19. Zenda S, Uchitomi Y, Morita T, YamaguchivT, Inoue A. Establishment of a research policy for supportive and palliative care in Japan. Jpn J Clin Oncol. 1;51(4):538-543,2021.4, doi: 1093/jjco/hyab008.
  20. Bando H, Kotani D, Tsushima T, Hara H, Kadowaki S, Kato K, Chin K, Yamaguchi K, Kageyama SI, Hojo H, Nakamura M, Tachibana H, Wakabayashi M, Fukutani M, Togashi Y, Fuse N, Nishikawa H, Kojima T. TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma. BMC Cancer. 20;20(1):336,2021.4, doi: 1186/s12885-020-06716-5.

邦文論文

  1. 秋元哲夫　食道胃接合部癌に対する放射線治療　消化器内科 3(5): 74-78, 2021.

2020年度

  1. Umemoto K, Takahashi H, Morizane C, Yamada I, Shimizu S, Shioji K, Yoshida Y, Motoya M, Mizuno N, Kojima Y, Terashima T, Uesugi K, Ueno M, Furuse J, Akimoto T, Ikeda M. FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study. Cancer Chemother Pharmacol. 2021 Mar;87(3):397-404. doi:10.1007/s00280-020-04206-w.
  2. Nakamura M, Kageyama SI, Seki M, Suzuki A, Okumura M, Hojo H, Motegi A, Akimoto T. Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy. Anticancer Res. 2021 Feb;41(2):829-834. doi: 10.21873/anticanres.14835.
  3. Yokota T, Ota Y, Fujii H, Kodaira T, Shimokawa M, Nakashima T, Monden N, Homma A, Ueda S, Akimoto T. Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2). Int J Clin Oncol. 2021 Feb;26(2):316-325. doi:10.1007/s10147-020-01817-4.
  4. Okano S, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, OgawaT, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Yokota T, Imamura Y, Ariizumi Y, Akimoto T, Hayashi R. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol. 2021 Feb 8;51(2):173-179. doi: 10.1093/jjco/hyaa220.
  5. Kageyama SI, Du J, Kaneko S, Hamamoto R, Yamaguchi S, Yamashita R, Okumura M, Motegi A, Hojo H, Nakamura M, Tsuchihara K, Akimoto T. Identification of the mutation signature of the cancer genome caused by irradiation. Radiother Oncol.2021 Feb;155:10-16. doi: 10.1016/j.radonc.2020.10.020.
  6. Sunakawa H, Hori K, Kadota T, Shinmura K, Yoda Y, Ikematsu H, Tomioka T, Akimoto T, Hayashi R, Fujii S, Yano T. Relationship between the microvascular patterns observed by magnifying endoscopy with narrow-band imaging and the depth of invasion in superficial pharyngeal squamous cell carcinoma. 2021 Jan;18(1):111-117. doi: 10.1007/s10388-020-00754-5.
  7. Tachibana H, Watanabe Y, Mizukami S, Maeyama T, Terazaki T, Uehara R, Akimoto T. End-to-end delivery quality assurance of computed tomography-based high-dose-rate brachytherapy using a gel dosimeter. 19(3):362-371, 2020.5, doi: 10.1016/j.brachy.2020.02.002
  8. Watanabe K, Mitsunaga S, Kojima M, Suzuki H, Irisawa A, Takahashi H, Sasaki M, Hashimoto Y, Imaoka H, Ohno I, Ikeda M, Akimoto T, Ochiai A. The "histological replacement growth pattern" represents aggressive invasive behavior in liver metastasis from pancreatic cancer. Cancer Med. 9(9):3130-3141, 2020.5, doi:10.1002/cam4.2954.
  9. Murakami M, Ishikawa H, Shimizu S, Iwata H, Okimoto T, Takagi M, Murayama S, Akimoto T, Wada H, Arimura T, Sato Y, Gosho M, Nakamura K, Sakurai H. Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group. Cancers (Basel). 25;12(6):1690, 2020.6, doi:10.3390/cancers12061690.
  10. Raturi VP, Hojo H, Hotta K, Baba H, Takahashi R, Rachi T, Nakamura N, Zenda S, Motegi A, Tachibana H, Ariji T, Motegi K, Nakamura M, Okumura M, Hirano Y, Akimoto T. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head. Radiat Oncol. 22;15(1):157, 2020.6, doi:10.1186/s13014-020-01592-6.
  11. Nishimura Y, Ishikura S, Shibata T, Kodaira T, Ito Y, Tsuchiya K, Murakami Y, Saitoh JI, Akimoto T, Nakata K, Yoshimura M, Teshima T, Toshiyasu T, Ota Y, Ishikawa K, Shimizu H, Minemura T, Nakamura K, Hiraoka M. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015). Int J Clin Oncol. 25(7):1250-1259, 2020.7, doi:10.1007/s10147-020-01665-2.
  12. Sasaki A, Kawazoe A, Eto T, Okunaka M, Mishima S, Sawada K, Nakamura Y, Kotani D, Kuboki Y, Taniguchi H, Kojima T, Doi T, Yoshino T, Akimoto T, Shitara K. Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer. ESMO Open. 2020 Jul. 4(Suppl 2):e000775. doi: 10.1136/esmoopen-2020-000775.
  13. Sato D, Motegi A, Kadota T, Kojima T, Bando H, Shinmura K, Hori K, Yoda Y, Oono Y, Zenda S, Ikematsu H, Akimoto T, Yano T. Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence. 17(3): 305-311, 2020.7, doi.org/10.1007/s10388-020-00715-y.
  14. Hojo H, Raturi V, Nakamura N, Arahira S, Akita T, Mitsunaga S, Nakamura M, Motegi A, Kageyama SI, Zenda S, Okumura M, Ikeda M, Akimoto T. Impact of Proton Beam Irradiation of an Anatomic Subsegment of the Liver for Hepatocellular Carcinoma. Practical Radiation Oncology. 10:4:264-271.2020.7. DOI: 10.1016/j.prro.2019.09.012.
  15. Gotohda N, Nomura S, Doi M, Karasawa K, Ohki T, Shimizu Y, Inaba Y, Takeda A, Takaki H, Anai H, Ikeda M, Sugimoto M, Akimoto T. Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients. JGH Open. 4(4): 722–728, 2020.8, doi:10.1002/jgh3.12325.
  16. Haiqin Zhang, Hojo H, Vijay P Raturi, Nakamura N, Nakamura M, Okumura M, Hirano Y, Motegi A, Kageyama SI, Zenda S, Akimoto T. Palliative Radiation Therapy for Macroscopic Hematuria Caused by Urothelial Cancer. Palliative Medicine Reports.1.2020.8. DOI: 10.1089/pmr.2020.0027.
  17. Okumura M, Motegi A, Zenda S, Nakamura N, Hojo H, Nakamura M, Hirano Y, Kageyama SI, Arahira S, Parshuram RV, Kuno H, Hayashi R, Tahara M, Itoh Y, Naganawa S, Akimoto T. Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation. Head Neck. 42(8):1775-1782.2020.8. doi: 10.1002/hed.26092.
  18. Nakamura M, Kageyama S-I, Udagawa H, Zenke Y, Yoh K, Niho S, Hojo H, Motegi A, Kirita K, Matsumoto S, Goto K, Akimoto T. Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancer. Radiother Oncol. 2020 Aug;149:14-17. doi: 10.1016/j.radonc.2020.04.056.
  19. Sakai T, Udagawa H, Matsumoto S, Yoh K, Nosaki K, Ikeda T, Zenke Y, Kirita K, Niho S, Akimoto T, Goto K, Ishii G. Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer. J Cancer Res Clin Oncol. Published online. 2020.9, doi:10.1007/s00432-020-03413-5.
  20. Kubo Y, Ito K, Sone M, Nagasawa H, Onishi Y, Umakoshi N, Hasegawa T, Akimoto T, Kusumoto M. Diagnostic Value of Model-Based Iterative Reconstruction Combined with a Metal Artifact Reduction Algorithm during CT of the Oral Cavity. AJNR Am J Neuroradiol. Published online.2020.9, doi:10.3174/ajnr.A6767.
  21. Sasaki A, Nakamura Y, Togashi Y, Kuno H, Hojo H, Kageyama S, Nakamura N, Takashima K, Kadota T, Yoda Y, Mishima S, Sawada K, Kotani D, Kawazoe A, Kuboki Y, Taniguchi H, Kojima T, Doi T, Yoshino T, Yano T, Kobayashi T, Akimoto T, Nishikawa H, Shitara K. Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer. Gastric Cancer.9, doi:10.1007/s10120-020-01058-4.
  22. Nakajo K, Yoda Y, Kadota T, Murano T, Shinmura K, Ikematsu H, Akimoto T, Yano T. Radial incision and cutting for dilation before endoscopic submucosal dissection in patients with esophageal cancer on the distal side of severe benign esophageal strictures. Dis Esophagus. Published online.2020.9, doi:10.1093/dote/doaa092.
  23. Yamamoto Y, Kadota T, Yoda Y, Hori K, Hatogai K, Kojima T, Fujii S, Akimoto T, Yano T. Review of early endoscopic findings in patients with local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma. 17(4):433-439, 2020.10, doi:10.1007/s10388-020-00734-9.
  24. Vijay P Raturi, Tochinai T, Hojo H, Rachi T, Hotta K, Nakamura N, Zenda S, Motegi A, Hirano Y, Baba H, Ohyoshi H, Nakamura M, Okumura M, Yanping Bei, Akimoto T. Dose-volume and Radiobiological Model-based Comparative Plan Evaluation for Gastrointestinal Toxicity Risk between Photon and Proton Irradiation in Localized Pancreatic Cancer without Distant Metastasis. Frontiers in Oncology-Radiation Oncology.10.doi.org/10.3389/fonc.2020.517061.
  25. Takahashi S, Ohno I, Ikeda M, Konishi M, Kobayashi T, Akimoto T, Kojima M, Morinaga S, Toyama H, Shimizu Y, Miyamoto A, Tomikawa M, Takakura N, Takayama W, Hirano S, Otsubo T, Nagino M, Kimura W, Sugimachi K, Uesaka K. Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-Label Multicenter Prospective Trial (JASPAC05). Ann Surg.Oct. Online ahead of print.
  26. Kageyama SI, Du J, Kaneko S, Hamamoto R, Yamaguchi S, Yamashita R, Okumura M, Motegi A, Hojo H, Nakamura M, Tsuchihara K, Akimoto T. Identification of the mutation signature of the cancer genome caused by irradiation. Radiother Oncol. S0167-8140(20)30856-2.2020.10. DOI:10.1016/j-radonc.2020.10.020.
  27. Sato D, Takamatsu T, Umezawa M, Kitagawa Y, Maeda K, Hosokawa N, Okubo K, Kamimura M, Kadota T, Akimoto T, Kinoshita T, Yano T, Kuwata T, Ikematsu H, Takemura H, Yokota H, Soga K. Distinction of surgically resected gastrointestinal stromal tumor by near-infrared hyperspectral imaging. Sci Rep. 2020 Dec.14;10(1):21852, doi: 10.1038/s41598-020-79021-7.
  28. Nakamura M, Kageyama S-I, Seki M, Suzuki A, Okumura M, Hojo H, Motegi A, Akimoto T. Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy. Anticancer res. 41(2)829-834. 2021.2. DOI: https://doi.org/10.21873/anticanres.14835.
  29. Yokota T, Ota Y, Fujii H, Kodaira T, Shimokawa M, Nakashima T, Monden N, Homma A, Ueda S, Akimoto T. Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2). Int J Clin Oncol.Feb.26(2):316-325, doi:10.1007/s10147-020-01817-4.
  30. Umemoto K, Takahashi H, Morizane C, Yamada I, Shimizu S, Shioji K, Yoshida Y, Motoya M, Mizuno N, Kojima Y, Terashima T, Uesugi K, Ueno M, Furuse J, Akimoto T, Ikeda M. FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study. Cancer Chemother Pharmacol.3.87(3):397-404. doi: 10.1007/s00280-020-04206-w.
  31. Okano S, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ogawa T, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Yokota T, Imamura Y, Ariizumi Y, Akimoto T, Hayashi R. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol. 2021 Feb 8;51(2):173-179. doi: 10.1093/jjco/hyaa220. PMID: 33290543
  32. Zenda S, Ryu A, Takashima A, Arai M, Takagi Y, Miyaji T, Mashiko T, Shimizu Y, Yamazaki N, Morizane C, Yamaguchi T, Kawaguchi T, Hanai A, Uchitomi Y, Oshiba F. Hydrocolloid dressing as a prophylactic use for hand-foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled study. BMJ Open. 10(10):e038276,2020.10,doi: 1136/bmjopen-2020-038276.
  33. Saiga M, Hosoya Y, Utsunomiya H, Kuramoto Y, Watanabe S, Tomita K, Aihara Y, Muto M, Hikosaka M, Kawaguchi T, Miyaji T, Yamaguchi T, Zenda S, Goto A, Sakuraba M, Kusano T, Miyabe K,Kuroki T, Yano T, Taminato M, Sekido M, Tsunoda Y, Satake T, Doihara H, Kimata Y. Protocol for a multicentre, prospective, cohort study to investigate patient satisfaction and quality of life after immediate breast reconstruction in Japan: the SAQLA study. BMJ Open. 11(2):e042099,2021.2,doi: 1136/bmjopen-2020-042099.
  34. Hirota H, Ito K, Kageyama SI, Tamamoto F, Karasawa K, Yoshimura R. Safety of radiotherapy for hemodialysis patients with cancer. Int J Clin Oncol. 25(5):978-983,2020.5, doi: 1007/s10147-020-01621-0
  35. Hojo H, Bhatt MLB, Suhel M, Wu CT, Bei Y, Nakamura M, Okumura M, Zhang H, Parmar D, Badajena A, Singh R, Kumar S, Katiyar T, Gaur J. Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation. Head Neck. 42：1045-1056,2020,doi:10.1002/hed.26083.

 

  1. 秋元哲夫.強度変調放射線治療.泌尿器外科. 33(11): 1397-1400,2021.
  2. 秋元哲夫. 陽子線棟. 泌尿器外科. 33(11): 1406-1411,2021.
  3. 秋元哲夫. III期非小細胞肺癌に対するIMRTおよびVMATの有効性. インナービジョン. 35・11; 72-73,2020.
  4. 秋元哲夫. 肉腫に対する陽子線治療. 日本臨床. 78(5); 511-518,2020.
  5. 秋元哲夫. 高リスク前立腺癌に対する粒子線治療の現状と可能性. 泌尿器外科. 33: 707-709,2020.
  6. 大原裕美、湯浅勇生、平田潤子、山根　健、秋元哲夫、永田　靖、木内良明. 陽子線治療がSturge-Weber症候群に伴うびまん性滲出性網膜剥離に有効であった1例. 日本眼科学会雑誌. 124(5): 432-440,2020.
  7. 秋元哲夫. 陽子線治療の技術的な進歩と可能性～強度変調陽子線治療を中心に～　ライフライン がんの先進医療. 36: 14-17,2020.

2019年度

  1. Imamura Y, Kiyota N, Ogawa G, Akimoto T, Fujii M, Hanai N, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1). Jpn J Clin Oncol. 49(11):1009-1015, 2019.
  2. Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma. Int J Clin Oncol. 24(1):60-67, 2019.
  3. Ohnishi K, Nakamura N, Harada H, Tokumaru S, Wada H, Arimura T, Iwata H, Sato Y, Sekino Y, Tamamura H, Mizoe JE, Ogino T, Ishikawa H, Kikuchi Y, Okimoto T, Murayama S, Akimoto T, Sakurai H. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan. Int J Radiat Oncol Biol Phys. 106(1):82-89, 2020.
  4. Kibe Y, Nakamura N, Kuno H, Hiyama T, Hayashi R, Zenda S, Motegi A, Hojo H, Nakamura M, Ariji T, Oyoshi H, Akimoto T. Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy. Int J Clin Oncol. 24(10):1182-1189, 2019.
  5. Head and Neck Cancer Study Group (HNCSG), Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N, Kodaira T, Zenda S, Fujii H, Tahara M, Yokota T, Akimoto T, Iwae S, Onitsuka T, Ogawa T, Okano S, Takahashi S, Shimizu Y, Yonezawa K, Hayashi R.  A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).  Jpn J Clin Oncol. 49(7):589-595, 2019.
  6. Nishio T, Tachibana H, Kase Y, Hotta K, Nakamura M, Tamura M, Terunuma T, Toshito T, Yamashita H, Ishikura S, Fuji H, Akimoto T, Nishimura Y. Liver phantom design and dosimetric verification in participating institutions for a proton beam therapy in patients with resectable hepatocellular carcinoma: Japan Clinical Oncology Group trial (JCOG1315C). Radiother Oncol. 29; 140:98-104, 2019.
  7. Nakamura N, Hotta K, Zenda S, Baba H, Kito S, Akita T, Motegi A, Hojo H, Nakamura M, Parshuram RV, Okumura M, Akimoto T. Hypofractionated proton beam therapy for centrally located lung cancer. J Med Imaging Radiat Oncol. 63(4):552-556, 2019.
  8. Kawaguchi H, Soejima T, Ishibashi N, Akiba T, Hasegawa M, Isobe K, Ito H, Imai M, Ejima Y, Hata M, Sasai K, Shimoda E, Oguchi M, Akimoto T; Japanese Radiation Oncology Study Group. National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group. J Radiat Res. 60(4):509-516, 2019.
  9. Motegi K, Tachibana H, Motegi A, Hotta K, Baba H, Akimoto T. Usefulness of hybrid deformable image registration algorithms in prostate radiation therapy. J Appl Clin Med Phys. 20(1): 229-236, 2019.
  10. Akamatsu H, Nakamura K, Ebara T, Inaba K, Itasaka S, Jingu K, Kosaka Y, Murai T, Nagata K, Soejima T, Takahashi S, Toyoda T, Toyoshima S, Nemoto K, Akimoto T. Organ-preserving approach via radiotherapy for small cell carcinoma of the bladder: an analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey. J Radiat Res. 2019.
  11. Nakamura M, Kageyama SI, Niho S, Okumura M, Hojo H, Motegi A, Nakamura N, Zenda S, Yoh K, Goto K, Akimoto T. Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung Cancer. Clin Lung Cancer. 20(3): e256-e264, 2019.
  12. Niho S, Hosomi Y, Okamoto H, Nihei K, Tanaka H, Hida T, Umemura S, Goto K, Akimoto T, Ohe Y. Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study. Jpn J Clin Oncol. 49(7):614-619, 2019.
  13. Okano S, Enokida T, Onoe T, Ota Y, Motegi A, Zenda S, Akimoto T, Tahara M. Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.Int J Clin Oncol. 24(7):789-797, 2019.
  14. Hojo H, Dohmae T, Hotta K, Kageyama SI, Baba H, Kohno R, Motegi A, Tsuchihara K, Akimoto T. Effect of 5-fluorouracil on cellular response to proton beam in esophageal cancer cell lines according to the position of spread-out Bragg peak. Acta Oncol. 11:1-8, 2019.
  15. Sasaki A, Nakamura Y, Mishima S, Kawazoe A, Kuboki Y, Bando H, Kojima T, Doi T, Ohtsu A, Yoshino T, Kuwata T, Akimoto T, Shitara K. Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer. Gastric Cancer. 22(4):793-802, 2019.
  16. Nozaki M, Kagami Y, Shibata T, Nakamura K, Ito Y, Nishimura Y, Kawaguchi Y, Saito Y, Nagata Y, Matsumoto Y, Akimoto T, Hiraoka M; Radiation Therapy Study Group, Japan Clinical Oncology Group. A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Jpn J Clin Oncol. 49(1):57-62, 2019.

2018年度

  1. Moriya S, Tachibana H, Hotta K, Nakamura N, Sakae T, Akimoto T. Range optimization for target and organs at risk in dynamic adaptive passive scattering proton beam therapy - A proof of concept. Phys Med. 56:66-73, 2018.
  2. Journy N, Indelicato DJ, Withrow DR, Akimoto T, Alapetite C, Araya M, Chang A, Chang JH, Chon B, Confer ME, Demizu Y, Dendale R, Doyen J, Ermoian R, Gurtner K, Hill-Kayser C, Iwata H, Kim JY, Kwok Y, Laack NN, Lee C, Lim DH, Loredo L, Mangona VS, Mansur DB, Murakami M, Murayama S, Ogino T, Ondrová B, Parikh RR, Paulino AC, Perkins S, Ramakrishna NR, Richter R, Rombi B, Shibata S, Shimizu S, Timmermann B, Vern-Gross T, Wang CJ, Weber DC, Wilkinson JB, Witt Nyström P, Yock TI, Kleinerman RA, Berrington de Gonzalez A. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiother Oncol. 24(1):60-67, 2018.
  3. Matsuzuka T, Kiyota N, Mizusawa J, Akimoto T, Fujii M, Hasegawa Y, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2). Jpn J Clin Oncol.49(1):37-41, 2019.
  4. Kageyama SI, Nihei K, Karasawa K, Sawada T, Koizumi F, Yamaguchi S, Kato S, Hojo H, Motegi A, Tsuchihara K, Akimoto T. Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients. Oncotarget. 4;9(34):23844, 2018.
  5. Kageyama SI, Nihei K, Karasawa K, Sawada T, Koizumi F, Yamaguchi S, Kato S, Hojo H, Motegi A, Tsuchihara K, Akimoto T. Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients. Oncotarget. 10;9(27):19368-19378, 2018.
  6. Nakamura N, Kawamori J, Takahashi O, Shikama N, Sekiguchi K, Takahashi T, Kato S, Ogita M, Motegi A, Akimoto T. Palliative radiotherapy for breast cancer patients with skin invasion: a multi-institutional prospective observational study. Jpn J Clin Oncol. 48(6):555-558, 2018.
  7. Nakamura N, Hojo H, Inoue K, Hotta K, Zenda S, Baba H, Onozawa M, Motegi A, Nakamura M, Kibe Y, Akimoto T. Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer. J Radiat Res. 1;59(4):456-461, 2018.
  8. Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma. Int J Clin Oncol. 24(1): 60-67, 2018.
  9. Nakamura M, Onozawa M, Motegi A, Hojo H, Zenda S, Nakamura N, Udagawa H, Kirita K, Matsumoto S, Umemura S, Yoh K, Niho S, Goto K, Akimoto T. Impact of prophylactic cranial irradiation on pattern of brain metastases as a first recurrence site for limited-disease small-cell lung cancer. J Radiat Res. 2018.
  10. Ishibashi N, Soejima T, Kawaguchi H, Akiba T, Hasegawa M, Isobe K, Ito H, Imai M, Ejima Y, Hata M, Sasai K, Shimoda E, Maebayashi T, Oguchi M, Akimoto T; Japanese Radiation Oncology Study Group. National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG). J Radiat Res. 9(4):477-483, 2018.
  11. Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, Shirato H, Sakurai H. Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan. Cancer Med.7(5):1870-1874, 2018.
  12. Iwata H, Ishikawa H, Takagi M, Okimoto T, Murayama S, Akimoto T, Wada H, Arimura T, Sato Y, Araya M, Mizoe JE, Gosho M, Nakamura K, Shirato H, Sakurai H. Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group. Cancer Med. 7(3): 677-689, 2018.
  13. Kodaira T, Kagami Y, Shibata T, Shikama N, Nishimura Y, Ishikura S, Nakamura K, Saito Y, Matsumoto Y, Teshima T, Ito Y, Akimoto T, Nakata K, Toshiyasu T, Nakagawa K, Nagata Y, Nishimura T, Uno T, Kataoka M, Yorozu A, Hiraoka M; Radiation Therapy Study Group of the Japan Clinical Oncology Group. Results of a multi-institutional, randomized, non-inferiority, phase 3 trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group study (JCOG0701). Ann Oncol. 29(4):992-997, 2018.
  14. Hirano Y, Onozawa M, Hojo H, Motegi A, Zenda S, Hotta K, Moriya S, Tachibana H, Nakamura N, Kojima T, Akimoto T. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma. Radiat Oncol. 13(1):23, 2018. 
  15. Taira T, Yoh K, Nagase S, Kubota K, Ohmatsu H, Niho S, Onozawa M, Akimoto T, Ohe Y, Goto K. Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer. Cancer Chemother Pharmacol. 81(3):565-572, 2018.
  16. Hashimoto Y, Motegi A, Akimoto T, Mitsuhashi N, Iizuka J, Tanabe K, Ishii Y, Kono S, Izumi S, Karasawa K. The 5-year outcomes of moderately hypofractionated radiotherapy (66 Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective study. Int J Clin Oncol. 23(1):165-172, 2018.

 

2017年度

  1. Nakamura N, Zenda S, Tahara M, Okano S, Hayashi R, Hojo H, Hotta K, Kito S, Motegi A, Arahira S, Tachibana H, Akimoto T. Proton beam therapy for olfactory neuroblastoma. Radiotherapy and Oncology.　2017, 122(3), 368–372.
  2. Demizu Y, Mizumoto M, Onoe T, Nakamura N, Kikuchi Y, Shibata T, Okimoto T, Hideyuki S, Akimoto T, Ono K, Daimon T, Murayama S. Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan. Cancer Sci. 2017, 108(5):972-977.
  3. Nibu KI, Hayashi R, Asakage T, Ojiri H, Kimata Y, Kodaira T, Nagao T, Nakashima T, Fujii T, Fujii H, Homma A, Matsuura K, Monden N, Beppu T, Hanai N, Kirita T, Kamei Y, Otsuki N, Kiyota N, Zenda S, Omura K, Omori K, Akimoto T, Kawabata K, Kishimoto S, Kitano H, Tohnai I, Nakatsuka T. Japanese Clinical Practice Guideline for Head and Neck Cancer. Auris Nasus Larynx. 44(4):375-380, 2017.

2016年度

  1. Wu C.T, Motegi A, Motegi K, Hotta K, Kohno R, Tachibana H, Kumagai M, Nakamura N, Hojo H, Niho S, Goto K, Akimoto T. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer. JJCO. 2016, 46(11), 1-7.
  2. Motegi A, Arahira S, Zenda S, Hayashi R, Fujii M, Akimoto T. Impact of expression of CD44, a cancer stem cell marker, on the treatment outcomes of intensity-modulated radiotherapy in patients with oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2016, 94(3): 461-8.
  3. Zenda S, Akimoto T, Mizumoto M, Hayashi R, Arahira S, Okumura T, Sakurai H. Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses. Radiotherapy and Oncology. 2016, 118(2), 267–271.
  4. Mizutani S, Takada Y, Kohno R, Hotta K, Tansho R, Akimoto T. Application of dose kernel calculation using a simplified Monte Carlo method to treatment plan for scanned proton beams. J Appl Clin Med Phys. 2016, 17(2), 5747.
  5. Hojo H, Domae T, Hotta K, Kohno R, Motegi A, Hirano Y, Onozawa M, Toshima M, Zenda S, Nakamura N, Kibe Y, Arahira S, Tsuchihara K, Akimoto T.  Evaluation of Cellular Response to Proton Beam in Esophageal Cancer Cell Lines.  Int J Radiat Oncol Biol Phys. 2016, 1, 96.
  6. Kohno R, Yamaguchi H, Motegi K, Hotta K, Nishioka S, Akimoto T. In Vivo Dosimetry of an Anthropomorphic Phantom Using the RADPOS for Proton Beam Therapy. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology. 2016, 5(3).
  7. Matsumoto S, Koba Y, Kohno R, Lee C, Bolch W.E, Kai M. Secondary neutron doses to pediatric patients during intracranial proton therapy: Monte Carlo simulation of the neutron energy spectrum and its organ doses. Health Phys. 2016, 110, 380-6.
  8. Kohno R, Yamaguchi H, Motegi K, Hotta K, Miyagishi T, Nishioka S, Dohmae T,  Akimoto T. In vivo dosimetry of an anthropomorphic phantom using the RADPOS for proton beam therapy. IJMPCERO . 2016, 5, 177-183.
  9. Ooishi M, Motegi A, Kawashima M, Arahira S, Zenda S, Nakamura N, Ariji T, Tokumaru S, Sakuraba M, Tahara M, Hayashi R, Akimoto T. Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer. Jpn J Clin Oncol. 2016, 46(10): 919-927.
  10. Zenke Y, Umemura S, Motegi A, Furukawa K, Kirita K, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Tsuboi M, Akimoto T, Goto K. Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non-Small Cell Lung Cancer. J Thorac Oncol. 2016, 11(7): 1181-3.
  11. Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, Shirato H, Sakurai H. Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan. Cancer Med. 2016, 5(7): 1519-25.
  12. Zenda S, Ota Y, Tachibana H, Ogawa H, Ishii S, Hashiguchi C, Akimoto T, Ohe Y, Uchitomi Y. A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients. J Radiat Res. 2016, 57(3): 301-62.
  13. Nakamura N, Takahashi O, Zenda S, Kawamori J, Ogita M, Onozawa M, Arahira S, Toshima M, Motegi A, Hirano Y, Hojo H, Akimoto T. Neuropathic Pain Features in Patients with Bone Metastases. Clin Oncol (R Coll Radiol) 2016, 28: 204-208.
  14. Hirano Y, Nakamura N, Zenda S, Hojo H, Motegi A, Arahira S, Toshima M, Onozawa M, Akimoto T. Incidence and severity of adverse events associated with re-irradiation for spine or pelvic bone metastases. Int J Clin Oncol. 2016, 21(3): 609-14.

2015年度

  1. Hotta K, Kohno R, Nagafuchi K, Yamaguchi H, Tansho R, Takada Y, and Akimoto T; Evaluation of monitor unit calculation based on measurement and calculation with a simplified Monte Carlo method for passive beam delivery system in proton beam therapy; J. Appl. Clin. Med. Phys. 2015, 16, 228-238
  2. Zenda S, Kawashima M, Arahira S, Kohno R, Nishio T, Tahara M, Hayashi R, Akimoto T.　Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.　Int J Clin Oncol. 20(3): 2015, 447-54.
  3. Mizowaki T, Aoki M, Nakamura K, Yorozu A, Kokubo M, Karasawa K, Kozuka T, Nakajima N, Sasai K, Akimoto T. Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study. J Radiat Res. 2015, 56(4): 750-6.
  4. Tahara M, Kiyota N, Mizusawa J, Nakamura K, Hayashi R, Akimoto T, Hasegawa Y, Iwae S, Monden N, Matsuura K, Fujii H, Onozawa Y, Homma A, Kubota A, Fukuda H, Fujii M. Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706). Cancer Sci. 2015, 106(6): 726-33.

2014年度

 

    1. Seiji Niho, Atsushi Motegi, and Tetsuo Akimoto. Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction. Gan To Kagaku Ryoho. 42(2): 144-147, 2015.
    2. Sadamoto Zenda, Mitsuhiko Kawashima, Satoko Arahira, Ryosuke Kohno, Teiji Nishio, Makoto Tahara, Ryuichi Hayashi, Tetsuo Akimoto. Late Toxicity of Proton Beam Therapy for Patients with the nasal cavity, para-nasal sinuses, or involving the skull base Malignancy: Importance of Long-term Follow-up. International Journal of Clinical Oncology. 2014.
    3. Motegi K, Kohno R, Ueda T, Shibuya T, Ariji T, Kawashima M, Akimoto T. Evaluating positional accuracy using megavoltage cone-beam computed tomography for IMRT with head-and-neck cancer. J Radiat Res. 55:568-74, 2014, 2014-10
粒子線医学開発分野（柏）
主な研究内容
メンバー
業績
共同研究プロポーザル
お問い合わせ
  • EPOC研究者一覧NEW